Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

attention deficit hyperactivity disorder/obesity

リンクがクリップボードに保存されます
ページ 1 から 227 結果

Suloexide in the Treatment of Early Stages of COVID-19

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Objective: To use sulodexide in patients that have early onset of COVID-19 symptoms to mitigate the progression of the disease process that can allow them to recover at home, and limit the need for hospital care and the more severe manifestation which includes fulminant respiratory failure, acute

Pilot Testing a Mobile App to Designed to Increase Physical Activity Among Pregnant and Postpartum Women

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
After contact is established and eligibility confirmed, Participants (N=30) will come to the Body Composition Laboratory on three separate occasions. The first will be baseline (~23-25 weeks pregnant), late pregnancy (35-37 weeks pregnant), and ~12 weeks postpartum. There will also be two check-ins

Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection

登録ユーザーのみが記事を翻訳できます
ログインサインアップ

Dietary Habits and Metabolic Response in Obese Children Whose Mothers Received an Intervention to Promote Healthy Eating

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
The aim of this study is evaluate the change in eating behaviors, metabolic condition, and nutritional status measured by anthropometry, in children with obesity who were prescribed a diet to reduce their body weight in the usual nutritional consultation, in comparison to children whose mothers

Oropharyngeal Dysphagia in Patients With COVID-19

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Background: Oropharyngeal dysphagia (OD) is a common complication in/post ICU patients that have been with intubation/mechanical ventilation or with tracheotomies or NG tubes, in patients with acute respiratory infection/pneumonia/respiratory insufficiency with a severe disease needing high

Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Background & rationale Sodium-glucose co-transporter-2 inhibitors (SGLT2i) have become available for the treatment of type 2 diabetes (T2D) in the U.S. in April 2013 (canagliflozin), January 2014 (dapagliflozin), and August 2014 (empagliflozin). In Italy, first-in-class dapagliflozin received

Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression

登録ユーザーのみが記事を翻訳できます
ログインサインアップ

Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Severe obesity, afflicting ~8% of adolescents in the U.S., is a serious and challenging medical and public health problem. The number and levels of cardiovascular risk factors are considerably higher in the context of severe obesity compared to milder forms of obesity. Approximately 85% of youth

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
AIMS OF STUDY The aim of this study is to investigate whether ingestion of curcumin will prevent hepatic insulin resistance (assessed by homeostatic model assessment of insulin resistance (HOMA-IR)) induced by short-term oral glucocorticoid (prednisolone) administration in overweight and obese

A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Severe asthma is associated with substantial morbidity, mortality, health-care costs, and impaired quality of life. Recurrent asthma exacerbations are a major problem in some patients and can predominate in a subgroup with eosinophilic airway inflammation. Mepolizumab is a humanised monoclonal

Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Patients will be recruited during 10/15/2019 through 12/31/2023 with the following inclusion criteria: 1) body mass index (BMI) 35 - 39 kg/m2 with comorbid conditions; 2) BMI 40+ kg/m2 with no comorbidities; 3) having a previous LGS; 4) having lost less than 10% total weight loss with this LSG; 5)

Food-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability of Children

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Phase 1 study will recruit a total of 172 healthy children who are matched by sex and age. Aside of being stunted, children must have normal weight for length z-score (not wasted or overweight). Data collection will be performed as follows: 1. Dietary intake of the children will be collected by 9

Aspirin (ASA) Therapy and Preeclampsia Prevention

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Rationale - The risk factors associated with preeclampsia (early-onset and late-onset, singleton deliveries) include the following maternal characteristics and clinical factors (Washington State, 2003-2008; ACOG 2018): age < 20 years, age >34 years, African-American race, marital status-single,

Metformin in Alzheimer's Dementia Prevention

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
STUDY PROCEDURES AT THE LEVEL OF THE PARTICIPANT. 1. Screening. We propose a 2-tier approach for screening, including telephone pre-screening followed by in-person screening. Telephone screening includes questions about inclusion and exclusion criteria including demographics (age, language), medical

Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and accounts for one third to one half of all heart failure admissions worldwide. It portrays a significant burden in terms of prevalence, morbidity and mortality. It is a complex clinical syndrome characterized by
Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge